Biochemical studies evaluating the chemopreventive potential of brucine in chemically induced mammary carcinogenesis of rats

Toxicology Mechanisms and Methods
Uma SaminathanRajendran Jayaganesh

Abstract

The present study was aimed to investigate the dose dependent chemopreventive activity of brucine against 7, 12-dimethylbenz (a) anthracene induced mammary gland tumorigenesis in rats. The mammary tumor was induced by a single dose of DMBA (25 mg/rat) injected subcutaneously near the mammary gland. We observed reduced body weight and increase in tumor incidence, the total number of tumors, and tumor volume in DMBA alone injected rats and also observed decreased antioxidant status (SOD, CAT, GPX, and GSH) and increased lipid peroxidation (TBARS and LOOH) in plasma and mammary tissues. Increased levels of CYP450, Cyt-b5 and decreased levels of phase II (GST and GR) biotransformation enzymes were noticed in the liver and mammary tissues. Further, increased levels of lipid profile (TC, TG, PL, and FFA) and lipoprotein (LDL and VLDL) were noticed. Whereas, decrease in the levels of HDL in plasma and decreased levels of PL and FFA in mammary tissues were observed. Oral administration of brucine in different doses (2, 4 and 8 mg/kg bw) inhibited the tumor incidence and restored the levels of biochemical markers near to normal in dose responsive manner. Biochemical findings are supported by histopathological studies. The results sugges...Continue Reading

References

Jun 1, 1979·Analytical Biochemistry·H OhkawaK Yagi
Nov 1, 1992·British Journal of Cancer·S DessíF M Baccino
Jan 1, 1985·Methods in Enzymology·I Carlberg, B Mannervik
Nov 1, 1987·Chemistry and Physics of Lipids·K Yagi
Mar 1, 1985·International Journal of Biometeorology·L C Wang
Jun 1, 1972·Analytical Biochemistry·A K Sinha
Feb 9, 1973·Science·J T RotruckW G Hoekstra
Jun 28, 1973·Clinica Chimica Acta; International Journal of Clinical Chemistry·K FalholtW Falholt
Jan 1, 1993·Annual Review of Nutrition·A H Merrill, J J Schroeder
Dec 24, 1997·Journal of Ethnopharmacology·R ValsarajU Nyman
Aug 10, 2000·European Journal of Biochemistry·J B SchulzJ Dichgans
Feb 24, 2001·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Y B Tripathi, S Chaurasia
Feb 15, 1963·Experientia·E BEUTLER, B M KELLY
Feb 20, 2004·Journal of Mammary Gland Biology and Neoplasia·H J Thompson, M Singh
May 12, 2004·Current Medicinal Chemistry·G PoliE Chiarpotto
Jan 31, 2006·Free Radical Biology & Medicine·Klas Blomgren, Henrik Hagberg
Jan 31, 2006·Toxicological Sciences : an Official Journal of the Society of Toxicology·Xukun DengWu Yin
Apr 13, 2006·Journal of Agricultural and Food Chemistry·Corinna E Rüfer, Sabine E Kulling
Apr 29, 2006·Chemico-biological Interactions·Gopalakrishnan RamakrishnanThiruvengadam Devaki
Jun 21, 2008·Clinical and Experimental Pharmacology & Physiology·Ekambaram GanapathySakthisekaran Dhanapal
Oct 28, 2008·Chemico-biological Interactions·Chandragiri Janakiraman ThirupurasundariSivasithambaram Niranjali Devaraj
Feb 16, 2012·International Journal of Nanomedicine·Jian-Min QinHe-Bai Shen
May 23, 2012·Molecular Medicine Reports·Yanping MaHua Ren
Apr 3, 2014·JAMA : the Journal of the American Medical Association·Lydia E Pace, Nancy L Keating
Sep 8, 2016·Journal of the National Cancer Institute·Joanne KotsopoulosUNKNOWN Hereditary Breast Cancer Clinical Study Group

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.